S B Patil, M Tamirat, K Khazhidinov, E Ardizzoni, M Atger, A Austin, E Baudin, M Bekhit, S Bektasov, E Berikova, M Bonnet, R Caboclo, M Chaudhry, V Chavan, S Cloez, J Coit, S Coutisson, Z Dakenova, B C De Jong, C Delifer, S Demaisons, J M Do, D Dos Santos Tozzi, V Ducher, G Ferlazzo, M Gouillou, U Khan, M Kunda, N Lachenal, A N LaHood, L Lecca, M Mazmanian, H McIlleron, M Moreau, M Moschioni, P Nahid, E Osso, L Oyewusi, S Panda, A Pâquet, P Thuong Huu, L Pichon, M L Rich, P Rupasinghe, N Salahud. Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.Trials. 2023, 24 (1): 773
T Dixon, K S Cadenhead. Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial.Trials. 2023, 24 (1): 775
Jesse Ross, Rubeshan Perumal, Allison Wolf, Mbali Zulu, Kevin Guzman, Boitumelo Seepamore, Karl Reis, Hlengiwe Nyilana, Senzo Hlathi, Radhamoney Narasimmulu, Ying Kuen K Cheung, K Rivet Amico, Gerald Friedland, Amrita Daftary, Jennifer R Zelnick, Kogieleum Naidoo, Max R O'Donnell. Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial.Trials. 2023, 24 (1): 776
A Juszczyk-Kalina, P Holas, T J Farchione. Effectiveness and mediators of change of an online CBT intervention for students with adjustment disorder-study protocol for a randomized controlled trial.Trials. 2023, 24 (1): 777
Dongke Wang, Dan Zhou, Xinghuang Liu, Zhiyue Xu, Tao Bai, Xiaohua Hou. Different dosages of vonoprazan for gastroesophageal reflux disease: study protocol for a pragmatic, crossover-cluster, randomized controlled trial with patient preference arms.Trials. 2023, 24 (1): 778
Sam Crosby, Adriana Malavisi, Liping Huang, Stephen Jan, Richard Holden, Bruce Neal. Factors influencing the time to ethics and governance approvals for clinical trials: a retrospective cross-sectional survey.Trials. 2023, 24 (1): 779
Eduardo F Marins, Eduardo L Caputo, Vitor L Krüger, Dirceu M Junior, Fabrício G Scaglioni, Fabricio B Del Vecchio, Tiago T Primo, Cristine L Alberton. Effectiveness of m-health-based core strengthening exercise and health education for public safety workers with chronic non-specific low back pain: study protocol for a superiority randomized controlled trial (SAFEBACK).Trials. 2023, 24 (1): 780
Wei Peng, Mengshi Yi, Xin Qi, Weili Qi, Chuan Li, Tianfu Wen. The effect of switch therapy to tenofovir versus entecavir maintenance on recurrence of hepatocellular carcinoma after surgery (SWITE): study protocol for a randomized controlled trial.Trials. 2023, 24 (1): 781
Amy Brenner, Haleema Shakur-Still, Rizwana Chaudhri, Projestine Muganyizi, Oladapo Olayemi, Monica Arribas, Aasia Kayani, Kiran Javid, Adenike Bello, Ian Roberts, . Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised placebo-controlled trial (I'M WOMAN).Trials. 2023, 24 (1): 782
Xavier Corominas-Teruel, Martina Bracco, Montserrat Fibla, Rosa Maria San Segundo, Marc Villalobos-Llaó, Cecile Gallea, Benoit Beranger, Monica Toba, Antoni Valero-Cabré, Maria Teresa Colomina. High-density transcranial direct current stimulation to improve upper limb motor function following stroke: study protocol for a double-blind randomized clinical trial targeting prefrontal and/or cerebellar cognitive contributions to voluntary motion.Trials. 2023, 24 (1): 783
Ellen Murphy, Katie Gillies, Frances Shiely. How do trial teams plan for retention during the design stage of the trial? A scoping review.Trials. 2023, 24 (1): 784
B Wertheim, E E Aarts, C de Roos, Y R van Rood. The effect of eye movement desensitization and reprocessing (EMDR) on abdominal pain in patients with irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial (EMDR4IBS).Trials. 2023, 24 (1): 785
Rui Qi Gao, Zhen Chang Mo, Hai Kun Zhou, Peng Fei Yu, Wei Dong Wang, Dan Hong Dong, Xi Sheng Yang, Xiao Hua Li, Gang Ji. A prospective, single-centre, randomized, double-blind controlled study protocol to study whether long-term oral metronidazole can effectively reduce the incidence of postoperative liver metastasis in patients with colorectal cancer.Trials. 2023, 24 (1): 786
Qiurong Xie, Jinsong Wu, Qi Zhang, Yanxin Zhang, Bo Sheng, Xiaoling Wang, Jia Huang. Neurobiomechanical mechanism of Tai Chi to improve upper limb coordination function in post-stroke patients: a study protocol for a randomized controlled trial.Trials. 2023, 24 (1): 788